Children breastfed for 6+ months showed 27% lower odds of developmental delays and neurodevelopmental conditions in comprehensive Israeli analysis of 570,000+ children, with sibling comparisons confirming protective effects.
The FDA has approved guselkumab (TREMFYA®) for moderately to severely active Crohn’s disease, supported by Phase 3 trial data showing clinical and endoscopic superiority over ustekinumab.
Chomps beef and turkey sticks pulled from shelves in multi-state recall after metal fragments discovered; manufacturer urges consumers to check lot codes and return affected products for refund.
A 1-unit increase in infant gut microbiota diversity at 1 month was associated with a 1.86 mm Hg lower systolic BP at 6 years—only in children breastfed for at least 6 months.